Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yukiya Yamamoto
Observed names:
Y Yamamoto,
Y. Yamamoto,
Yamamoto Yukiya,
Yamamoto, Y.
Institutions:
Fujita Health University,
Chubu University
Observed institutions:
Beth Israel Deaconess Medical Center,
Harvard University,
Fujita Health University,
Chubu University,
Nagoya University Hospital,
Harvard Stem Cell Institute,
Nagoya University,
Kumamoto University
show all 8
ORCID:
0000-0002-7439-4925
Observed ORCID:
0000-0002-7439-4925
OpenAlex ID:
A5082809317
Works
51
Awards
2
Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies
2001
·
Y. Yamamoto
, H Kiyoi
, et al.
·
Blood
·
1,255
Block of C/EBPα function by phosphorylation in acute myeloid leukemia with FLT3 activating mutations
2006
·
Hanna S. Radomska
, Daniela S. Bassères
, et al.
·
The Journal of Experimental Medicine
·
223
PDF
BCOR as a novel fusion partner of retinoic acid receptor alpha in a t(X;17)(p11;q12) variant of acute promyelocytic leukemia
2010
·
Yukiya Yamamoto
, Sachiko Tsuzuki
, et al.
·
Blood
·
153
Selective apoptosis of tandemly duplicated FLT3-transformed leukemia cells by Hsp90 inhibitors
2002
·
Y Minami
, H Kiyoi
, et al.
·
Leukemia
·
111
In vivo treatment of mutant FLT3-transformed murine leukemia with a tyrosine kinase inhibitor
2000
·
M Zhao
, H Kiyoi
, et al.
·
Leukemia
·
85
In vitro anticancer activity of methyl caffeate isolated from Solanum torvum Swartz. fruit
2015
·
C. Balachandran
, N. Emi
, et al.
·
Chemico-Biological Interactions
·
81
Requirement for delivery of signals by physical interaction and soluble factors from accessory cells in the induction of receptor-mediated T cell proliferation. Effectiveness of IFN-gamma modulation of accessory cells for physical interaction with T cells.
1989
·
K Kawakami
, Y Yamamoto
, et al.
·
The Journal of Immunology
·
66
Clarifying the Impact of Polycomb Complex Component Disruption in Human Cancers
2014
·
Yukiya Yamamoto
, Akihiro Abe
, et al.
·
Molecular Cancer Research
·
61
The prognostic significance of EBV DNA load and EBER status in diagnostic specimens from diffuse large B‐cell lymphoma patients
2015
·
Akinao Okamoto
, Masamitsu Yanada
, et al.
·
Hematological Oncology
·
51
PDF
Construction and molecular characterization of a T-cell receptor-like antibody and CAR-T cells specific for minor histocompatibility antigen HA-1H
2014
·
Y Inaguma
, Y Akahori
, et al.
·
Gene Therapy
·
51
In vivo Effects of a Histone Deacetylase Inhibitor, FK228, on Human Acute Promyelocytic Leukemia in NOD/Shi‐scid/scid Mice
2001
·
Hiroshi Kosugi
, Masafumi Ito
, et al.
·
Japanese Journal of Cancer Research
·
51
PDF
PU.1-c-Jun interaction is crucial for PU.1 function in myeloid development
2022
·
Xinhui Zhao
, Boris Bartholdy
, et al.
·
Communications Biology
·
49
PDF
FLT3 tyrosine kinase as a target molecule for selective antileukemia therapy
2001
·
Tomoki Naoe
, Hitoshi Kiyoi
, et al.
·
Cancer Chemotherapy and Pharmacology
·
41
CD19-positive lymphocyte count is critical for acquisition of anti-SARS-CoV-2 IgG after vaccination in B-cell lymphoma
2022
·
Akinao Okamoto
, Hidetsugu Fujigaki
, et al.
·
Blood Advances
·
39
PDF
TP53 mutations in older adults with acute myeloid leukemia
2016
·
Masamitsu Yanada
, Yukiya Yamamoto
, et al.
·
International Journal of Hematology
·
37
Prognostic significance of Epstein–Barr virus DNA detection in pretreatment serum in diffuse large B‐cell lymphoma
2015
·
Akinao Okamoto
, Masamitsu Yanada
, et al.
·
Cancer Science
·
30
PDF
Phase 1 Clinical Trial of PPMX‐T003, a Novel Human Monoclonal Antibody Specific for Transferrin Receptor 1, to Evaluate Its Safety, Pharmacokinetics, and Pharmacodynamics
2022
·
Yoichiro Ogama
, Yuji Kumagai
, et al.
·
Clinical Pharmacology in Drug Development
·
18
ETV6‐LPXN fusion transcript generated by t(11;12)(q12.1;p13) in a patient with relapsing acute myeloid leukemia with NUP98‐HOXA9
2015
·
Akihiro Abe
, Yukiya Yamamoto
, et al.
·
Genes Chromosomes and Cancer
·
17
A varicella outbreak in B-cell lymphoma patients receiving rituximab-containing chemotherapy
2014
·
Akinao Okamoto
, Akihiro Abe
, et al.
·
Journal of Infection and Chemotherapy
·
15
BCOR as a Novel Fusion Partner of Retinoic Acid Receptor Alpha In a t(X;17)(p11;q12) Variant of Acute Promyelocytic Leukemia
2010
·
Yukiya Yamamoto
, Sachiko Tsuzuki
, et al.
·
Blood
·
11
Chronic Myeloid Leukemia following Chemotherapy with 5'-deoxy-5-fluorouridine for Gastric Cancer
2008
·
Motohiro Tsuzuki
, Kousuke Handa
, et al.
·
Internal Medicine
·
11
PDF
Successful Pregnancy in a Patient with Chronic Myeloid Leukemia under Treatment with Imatinib
2009
·
Motohiro Tsuzuki
, Youko Inaguma
, et al.
·
Internal Medicine
·
10
PDF
Rearrangement of VPS13B, a causative gene of Cohen syndrome, in a case of RUNX1–RUNX1T1 leukemia with t(8;12;21)
2017
·
Akihiro Abe
, Yukiya Yamamoto
, et al.
·
International Journal of Hematology
·
9
Functionally Deregulated AML1/RUNX1 Cooperates with BCR-ABL to Induce a Blastic Phase-Like Phenotype of Chronic Myelogenous Leukemia in Mice
2013
·
Kiyoko Yamamoto
, Shinobu Tsuzuki
, et al.
·
PLoS ONE
·
9
PDF
Truncated RUNX1 Generated by the Fusion of RUNX1 to Antisense GRIK2 via a Cryptic Chromosome Translocation Enhances Sensitivity to Granulocyte Colony-Stimulating Factor
2020
·
Akihiro Abe
, Yukiya Yamamoto
, et al.
·
Cytogenetic and Genome Research
·
8
PDF
Show more works
View as search
Works count:
51
Citation count:
2,557
H-index:
17
I10-index:
22
Year
Topic
Type